Tactics of antihypertensive therapy during COVID-19 pandemic
Results of foreign and Russian studies indicate a higher mortality rate of patients with concomitant cardiovascular diseases (CVD) due to the new coronavirus infection COVID-19. It has been proven that arterial hypertension, as one of the significant risk factors for the development of concomitant c...
Enregistré dans:
Auteurs principaux: | Valery I. Podzolkov, Anna Е. Bragina, Yulia N. Rodionova, Galina I. Bragina, Ekaterina E. Bykova |
---|---|
Format: | article |
Langue: | RU |
Publié: |
"Consilium Medicum" Publishing house
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a39b4a68a3584c2ca850552d17dbde5a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Menores niveles tisulares de la enzima convertidora de angiotensina I homologa (ECA-2) y angiotensina-(1-9) están asociados a mayor remodelamiento de la pared aórtica de ratas hipertensas
par: Ocaranza,María Paz, et autres
Publié: (2010) -
Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19
par: Irina E. Chazova, et autres
Publié: (2020) -
Hiperaldosteronismo primario y embarazo: Lecciones obtenidas de 2 casos clínicos
par: Germain A,Alfredo M, et autres
Publié: (2002) -
Actividad de 11 beta hidroxiesteroide dehidrogenasa tipo 2 en hipertensos chilenos
par: Mosso G,Lorena, et autres
Publié: (2002) -
Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs
par: Darcy Adin, et autres
Publié: (2021)